Search Investor Updates

Investor Update provides you with up to date and informative articles about the investment climate in Australia.

US pharmaceutical company invests in Australian R&D
27 Jul 2016
Provectus Biopharmaceuticals, a NYSE-listed developer of pharmaceutical products and therapies focusing on cancer, has established a new Australian subsidiary and office in Sydney.
Read article...
Australian medtech companies awarded BARDA funding
12 Jul 2016
A number of Australian wound-healing companies have recently gained funding from the US Biomedical Advanced Research and Development Authority (BARDA), proving the international competitiveness of the ...
Read article...
Recipients of Australian tropical medicine commercialisation grants announced
16 Jun 2016
Applications for ATMC grants program closed in March and the Australian organisations that have been offered grants have now been announced.
Read article...
Update on Australian Medical Research Advisory Board
28 Apr 2016
The Australian Government has announced appointments to the Australian Medical Research Advisory Board, set-up to advise how funds held in the Medical Research Future Fund should be deployed.
Read article...
New Nanoscience Hub at Sydney University
7 Apr 2016
The Australian Institute for Nanoscale Science and Technology at Sydney University will open a new Nanoscience Hub*on April 20.
Read article...
UK fintech launches point-of-payment rating system in Australia
31 Mar 2016
The UK fintech start-up, truRating – a point-of-payment rating system – has launched in Australia. The award-winning consumer ratings company has secured partnerships with some of Australia’s top-tier ...
Read article...
US pharmaceutical giant invests A$21 million in South Australia cancer drug facility
24 Mar 2016
Pfizer Australia, a subsidiary of the US biopharmaceutical giant, Pfizer Inc, is to expand operations in Adelaide, with an investment of A$21 million at its facility in Thebarton, in the city’s inner- ...
Read article...
Koreans invest in Australian biotech
23 Feb 2016
International investors have closed a A$13 million Series B financing round for Australian clinical stage medical company, Elastagen Pty Ltd.
Read article...
Australian medical technology company secures US$6 million from Global Health Investment Fund
17 Feb 2016
Atomo Diagnostics, a Sydney-based medical technology company, has secured US$6 million from the US-based Global Health Investment Fund (GHIF) to increase production of its rapid diagnostic test (RDT) ...
Read article...
Cancer Therapeutics CRC in multi-million dollar licensing deal
16 Feb 2016
In one of the largest preclinical deals in Australian biotech history, the Melbourne-based research company Cancer Therapeutics CRC (CTx) has a promising new cancer drug program licensed with MSD, kno ...
Read article...
A$250 million Biomedical Translation Fund to bridge gap between commercialisation and research
22 Jan 2016
The A$250 million Biomedical Translation Fund, announced by the Australian Government in late 2015, will invest in promising biomedical discoveries, help bridge the gap between research and commercial ...
Read article...
Pilot vaccine facility opened in Victoria
23 Dec 2015
Global pharmaceutical giant, GlaxoSmithKline (GSK), has opened a pilot vaccine facility in Boronia, Victoria, which uses ground-breaking new technology for the delivery of vaccines.
Read article...
Australia invests in the future
14 Dec 2015
Australia is investing in the future with a far-reaching A$1.1 billion National Innovation and Science Agenda announced by the Australian Prime Minister Malcolm Turnbull on 7 December 2015.
Read article...
Australian scientists attract landmark funding for malaria drug development
14 Nov 2015
Landmark funding for malaria drug development has been announced by Australia’s Minister for Trade and Investment, Andrew Robb, and the Premier of Queensland, Annastacia Palaszczuk.
Read article...
Australian Tropical Medicine Commercialisation Grants Programme launched
13 Nov 2015
Australia’s Trade and Investment Minister, Andrew Robb, has officially launched the A$8.5 million Australian Tropical Medicine Commercialisation Grants Programme (ATMCGP).
Read article...
Johnson & Johnson in innovation collaboration with the Queensland Government
8 Oct 2015
The Queensland Government has announced a collaboration with the US pharmaceutical and healthcare giant, Johnson & Johnson, to develop and commercialise healthcare innovations in Queensland.
Read article...
Leading Chinese pharmaceutical company and Australian university collaborate in drug discoveries
23 Sep 2015
Leading Chinese speciality pharmaceutical company, Yabao Pharmaceutical, has announced a collaboration with the University of South Australia to develop new treatments for cancer.
Read article...
Australian biotech partners with AstraZeneca
22 Sep 2015
The Melbourne-based ASX-listed pharmaceutical company Starpharma has signed a licencing agreement with global biopharmaceutical AstraZeneca.
Read article...
Swiss global healthcare conglomerate acquires Australian biotech
21 Sep 2015
The Switzerland-based global healthcare company, Novartis, has acquired the Australian biotech Spinifex, in a deal worth US$700 million.
Read article...
Multi-billion dollar investment in medical research
26 Aug 2015
Legislation has passed through the Australian parliament to establish the landmark Medical Research Future Fund – the largest fund of its kind the world – which will significantly strengthen Australia ...
Read article...